Rock Springs Capital Management LP: 13F holdings
CIK 15957252026Q2
| Positions | 104 |
|---|
| Reported value | $2.0bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 104 (+4 vs prior quarter) |
|---|
| Reported value | $2.0bn (+20.8%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| RVMD REVOLUTION MEDICINES INC | 1,105,210 | $207.0m | 10.1% |
| TVTX TRAVERE THERAPEUTICS INC | 2,179,069 | $123.8m | 6.0% |
| LLY ELI LILLY & CO | 98,700 | $118.4m | 5.8% |
| MDGL MADRIGAL PHARMACEUTICALS INC | 174,999 | $94.0m | 4.6% |
| MIRM MIRUM PHARMACEUTICALS INC | 798,145 | $93.4m | 4.6% |
| RYTM RHYTHM PHARMACEUTICALS INC | 692,598 | $76.9m | 3.8% |
| KYMR KYMERA THERAPEUTICS INC | 453,156 | $52.0m | 2.5% |
| ARGX ARGENX SE | 52,750 | $48.9m | 2.4% |
| ASCENDIS PHARMA A/S | 168,750 | $45.0m | 2.2% |
| XENE XENON PHARMACEUTICALS INC | 683,907 | $41.3m | 2.0% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1595725")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples